PROCEPT BioRobotics Corp (PRCT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, PROCEPT BioRobotics reported revenue of $308.1M, up 37.2% from $224.5M the year before. Net income was -$95.6M (a -31.0% net margin), or -$1.72 per diluted share. Gross margin was 63.7% and operating margin was -33.7%. Operating activities generated -$49.0M of cash, leaving -$58.3M of free cash flow. At fiscal year end, PROCEPT BioRobotics held $508.1M in total assets against $142.2M in total liabilities, including $286.5M of cash and equivalents.
Open the full interactive PROCEPT BioRobotics financials → Quarterly statements, key ratios, valuation history and price charts.
PROCEPT BioRobotics Key Stats
| Share Price | $19.10 |
|---|---|
| Market Cap | $1.09B |
| Revenue YoY Growth | +37.2% |
| 52-Week Range | $16.69 – $36.95 |
| Shares Outstanding | 57.1 million (basic, 2026 Q2) |
PROCEPT BioRobotics Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $34.5M | $75.0M | $136.2M | $224.5M | $308.1M |
| Gross Profit | $15.9M | $37.1M | $71.0M | $137.1M | $196.2M |
| Operating Income | -$54.2M | -$80.7M | -$109.2M | -$96.6M | -$103.9M |
| Pre-Tax Income | -$59.9M | -$87.2M | -$105.9M | -$91.4M | -$95.4M |
| Income Tax | $0 | $0 | $0 | $0 | $190,000 |
| Net Income | -$59.9M | -$87.2M | -$105.9M | -$91.4M | -$95.6M |
| Diluted EPS | -$3.63 | -$1.96 | -$2.24 | -$1.75 | -$1.72 |
PROCEPT BioRobotics Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $83.3M | $76.4M | $83.1M | $94.5M |
| Net Income | -$21.4M | -$29.8M | -$31.6M | -$26.9M |
| Diluted EPS | -$0.38 | -$0.54 | -$0.56 | -$0.47 |
PROCEPT BioRobotics Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $304.3M | $221.9M | $257.2M | $333.7M | $286.5M |
| Current Assets | $326.2M | $272.6M | $350.6M | $481.8M | $450.4M |
| Total Assets | $337.0M | $309.3M | $404.7M | $534.0M | $508.1M |
| Current Liabilities | $16.2M | $35.3M | $45.9M | $53.1M | $65.8M |
| Total Long-Term Debt | $50.0M | $51.2M | $51.3M | $51.5M | $51.6M |
| Total Liabilities | $69.9M | $112.3M | $124.0M | $131.8M | $142.2M |
| Shareholders' Equity | $267.1M | $197.1M | $280.8M | $402.2M | $365.9M |
PROCEPT BioRobotics Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$57.3M | -$80.4M | -$108.0M | -$99.2M | -$49.0M |
| Cash From Investing | -$592,000 | -$2.7M | -$25.2M | -$4.4M | -$9.4M |
| Cash From Financing | $262.1M | $3.6M | $167.8M | $180.1M | $11.2M |
| Free Cash Flow | -$57.9M | -$83.0M | -$133.2M | -$103.6M | -$58.3M |
Figures from PROCEPT BioRobotics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full PROCEPT BioRobotics financials page for every line item.
PROCEPT BioRobotics Company Profile
| Ticker | PRCT |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | San Jose, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001588978 |
Frequently Asked Questions
What was PROCEPT BioRobotics' revenue in fiscal 2025?
PROCEPT BioRobotics (PRCT) reported revenue of $308.1M for fiscal 2025.
What is PROCEPT BioRobotics' annual revenue history?
PROCEPT BioRobotics' annual revenue by fiscal year: 2021: $34.5M; 2022: $75.0M; 2023: $136.2M; 2024: $224.5M; 2025: $308.1M.
What was PROCEPT BioRobotics' net income in fiscal 2025?
PROCEPT BioRobotics reported net income of -$95.6M for fiscal 2025.
What was PROCEPT BioRobotics' earnings per share (EPS) in fiscal 2025?
PROCEPT BioRobotics' diluted EPS was -$1.72 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did PROCEPT BioRobotics generate in fiscal 2025?
PROCEPT BioRobotics generated -$58.3M of free cash flow in fiscal 2025.
What was PROCEPT BioRobotics' revenue last quarter?
In its most recent reported quarter (2026 Q2), PROCEPT BioRobotics reported revenue of $94.5M.
How much debt does PROCEPT BioRobotics have?
PROCEPT BioRobotics reported $51.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of PROCEPT BioRobotics are outstanding?
PROCEPT BioRobotics reported a weighted average of 57.1 million basic shares outstanding in 2026 Q2.
What is PROCEPT BioRobotics' market cap?
Based on its latest closing price, PROCEPT BioRobotics (PRCT) has a market capitalization of about $1.09B.
When does PROCEPT BioRobotics' fiscal year end?
PROCEPT BioRobotics' fiscal year end, as registered with the SEC, is December 31.
Where is PROCEPT BioRobotics headquartered?
PROCEPT BioRobotics lists its business address in San Jose, California in its SEC filings.